BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Papathanasiou AE, Spyropoulos F, Michael Z, Joung KE, Briana DD, Malamitsi-Puchner A, Mantzoros CS, Christou H. Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension. Int J Mol Sci 2021;22:1435. [PMID: 33535425 DOI: 10.3390/ijms22031435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kosmas K, Michael Z, Papathanasiou AE, Spyropoulos F, Adib E, Jasuja R, Christou H. Skeletal Muscle Dysfunction in Experimental Pulmonary Hypertension. Int J Mol Sci 2022;23:10912. [PMID: 36142826 DOI: 10.3390/ijms231810912] [Reference Citation Analysis]
2 Mccarthy BE, Mcclelland RL, Appleby DH, Moutchia JS, Minhas JK, Min J, Mazurek JA, Smith KA, Fritz JS, Pugliese SC, Urbanowicz RJ, Holmes JH, Palevsky HI, Kawut SM, Al-naamani N. BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension. Chest 2022;162:436-447. [DOI: 10.1016/j.chest.2022.02.041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Aragón-herrera A, Feijóo-bandín S, Anido-varela L, Moraña-fernández S, Roselló-lletí E, Portolés M, Tarazón E, Gualillo O, González-juanatey JR, Lago F. Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases. JPM 2022;12:1021. [DOI: 10.3390/jpm12071021] [Reference Citation Analysis]
4 Jia M, Guan C, Tao J, Zhou Y, Yan L. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/5042762] [Reference Citation Analysis]